

Cover Story
Free
By Matthew Bin Han Ong
All scheduled cancer care across Ukraine has been stopped as more than 60 hospitals have been badly damaged in the course of Russia’s invasion, Ukrainian oncologists say.
In Brief


Funding Opportunities
Clinical Roundup
Drugs & Targets


NCI Trials


NCI Trials for March 2022
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - TIL + pembro regimen achieves 24% response rate in solid epithelial tumors, marking a step forward in immunotherapy research
- The White House “skinny budget” document cuts NIH by nearly 40%
The cuts are consistent with the previously leaked “passback” document - NIH cuts threaten U.S. edge in biomedical research: “We are giving China the opportunity of a lifetime”
Cancer research also took center stage at Senate appropriations hearing - In The Headlines: Are cancer registries on the chopping block, and what does it mean if they are?
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated